Company Name: Sorrento Therapeutics, Inc.   

Sorrento Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in the development of treatments for oncology, autoimmune diseases and inflammation. The company’s platforms include:

  • Antibody-drug conjugates (ADCs)
  • Biosimilars
  • Cell-internalizing antibodies
  • Cellular therapy
  • Immuno-oncology antibodies

Ticker Symbol: SRNE (NASDAQ)

Company Website:

Social Media: Sorrento Therapeutics LinkedIn

Headquarters: San Diego, CA